Abstract Background Coronavirus disease-19 (COVID-19) due to acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection is the largest emergency that humanity had …

Vaccines have represented the breakthrough in the fight against COVID-19. Based on
reported headache attacks after vaccination in randomized controlled trials, we focused on …

Recent evidence suggests that headache is common in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections [1]. Although universal vaccination appears the …

Background Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination.
Whether patients with history of headache suffer more from vaccination-induced headaches …

The advent and availability of coronavirus disease 2019 (COVID-19) vaccines has led
patients to pose a number of questions to their headache healthcare providers. In retrospect …

Background This longitudinal cohort study aimed to investigate changes in migraine-related
outcomes following COVID-19 infection and vaccination. Methods We identified 547 …

Background Headache is the most frequent neurological adverse event following SARS-
CoV-2 vaccines. We investigated the frequency, characteristics, and factors associated with …

Abstract Background Coronavirus disease 2019 (COVID‐19) vaccine–related side effects
are a key concern with the emergence of various types of vaccines in the market. We aimed …

Introduction This study aimed to assess the prevalence and clinical characteristics of
headaches, in particular secondary headaches. Materials and Methods This observational …

The novel coronavirus SARS-CoV-2 causes the infectious disease COVID-19. Newly
developed mRNA vaccines can prevent the spread of the virus. Headache is the most …